As women have started having babies later in life, the number of patients undergoing IVF treatment has increased significantly.
Medical care can be life-changing, but it also comes at a price, as some couples go deep into debt to pay for medical care that health insurance doesn’t always cover. Some research has questioned the effectiveness of newer aspects of fertility treatment, such as genetic screening, and some patients have filed lawsuits alleging that faulty chemicals destroyed their embryos. Private equity firms, seeing the industry’s rapid growth, have bought some of the country’s largest fertility clinics.
The New York Times is looking to hear from readers who can share their recent experiences with IVF treatment. Hearing from patients helps us better understand where to focus our reports.
We will not publish any part of your response to this questionnaire without talking to you first. We will not share your contact information outside the Times newsroom and will only use it to contact you. If you feel more comfortable sharing your story with us anonymously, please visit our tips page.
